Evidence map›Paper›PMID 42801581›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Multimodal Imaging of Hypoxia, Metabolism and pH in Feline Sarcoma Using Hyperpolarized

Martin Grashei, Tanja Groll, Stephanie Kahl, Silke Baer, Elisabeth Bliemsrieder, Frits H A van Heijster, Andre Wendlinger, Pascal Wodtke, Jorge Cabello, Susan Notohamiprodjo and 8 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Martin GrasheiTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-5019-9359
Tanja GrollComparative Experimental Pathology (CEP), Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-9049-9145
Stephanie KahlClinic of Small Animal Medicine, LMU Munich, Munich, Germany.
Silke BaerTUM School of Medicine and Health, Center for Preclinical Research, TUM University Hospital, Technical University of Munich, Munich, Germany.
Elisabeth BliemsriederTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.
Frits H A van HeijsterTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.
Andre WendlingerTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0009-0003-2056-8752
Pascal WodtkeTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-6109-4261
Jorge CabelloTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.
Susan NotohamiprodjoTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-1312-1245
Christian LohrmannTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.
Markus SchwaigerTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.
Wolfgang A WeberTUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-7854-4345
Katja SteigerComparative Experimental Pathology (CEP), Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-7269-5433
Andrea Meyer-LindenbergClinic of Small Animal Surgery and Reproduction, Centre of Clinical Veterinary Medicine, LMU Munich, Munich, Germany.
Johannes HirschbergerClinic of Small Animal Medicine, LMU Munich, Munich, Germany.
Christine Baumgartner *TUM School of Medicine and Health, Center for Preclinical Research, TUM University Hospital, Technical University of Munich, Munich, Germany.
Franz Schilling *TUM School of Medicine and Health, Department of Nuclear Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-5239-4628

Funding

Deutsche Forschungsgemeinschaft (DFG, German Research Foundation Sonderforschungsbereich 824)Emmy Noether programme 391523415European Union's Horizon 2020 research and innovation program 820374
6 · The paper itself

Abstract

Direct in vivo characterization of the interplay between tumor hypoxia, acidosis, and metabolic reprogramming remains a major translational challenge. Here, we establish a clinically deployable simultaneous PET/MRI workflow on a clinical 3 T system that combines hyperpolarized

Indexed as

cathyperpolarizationhypoxiametabolismPET/MRIpHsarcoma

Identifiers

PMID42801581
PMCPMC13616244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.